ID: ALA3612238

Max Phase: Preclinical

Molecular Formula: C10H18ClNO2

Molecular Weight: 183.25

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC(=O)[C@@H]1[C@H]2CCC[C@@H]1NCC2.Cl

Standard InChI:  InChI=1S/C10H17NO2.ClH/c1-13-10(12)9-7-3-2-4-8(9)11-6-5-7;/h7-9,11H,2-6H2,1H3;1H/t7?,8?,9-;/m1./s1

Standard InChI Key:  XWBKXOKNZUEJGP-BTVWAASQSA-N

Associated Targets(non-human)

Mu opioid receptor-like OR2 18 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 183.25Molecular Weight (Monoisotopic): 183.1259AlogP: 0.94#Rotatable Bonds: 1
Polar Surface Area: 38.33Molecular Species: BASEHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.46CX LogP: 0.94CX LogD: -1.09
Aromatic Rings: 0Heavy Atoms: 13QED Weighted: 0.61Np Likeness Score: 0.95

References

1. Nieto CT, Gonzalez-Nunez V, Rodríguez RE, Diez D, Garrido NM..  (2015)  Design, synthesis, pharmacological evaluation and molecular dynamics of β-amino acids morphan-derivatives as novel ligands for opioid receptors.,  101  [PMID:26134550] [10.1016/j.ejmech.2015.06.025]

Source